Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Clinical Trial, Phase II"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Minassian%2C+Angela+M%22&type=Person&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22
/vufind/Search/Results?lookfor=%22Minassian%2C+Angela+M%22&type=Person&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22
Search /vufind/Search2/Results?lookfor=%22Minassian%2C+Angela+M%22&type=Person&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22
PubPharm (11)
1
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3) : A randomised controlled trial
enthalten in:
The Journal of infection
| 2023
von
Kelly, E.
|
Greenland, M.
|
de Whalley, P.
| +31
Wird geladen...
2
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK : eight-month analyses of the COV-BOOST trial
enthalten in:
The Journal of infection
| 2023
von
Liu, X.
|
Munro, A.
|
Wright, A.
| +59
Wird geladen...
3
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST) : a multicentre, blinded, phase 2, randomised trial
enthalten in:
The Lancet. Infectious diseases
| 2022
von
Munro, A.
|
Feng, S.
|
Janani, L.
| +153
CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1092-1093. - PMID 35550263
Wird geladen...
4
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial
enthalten in:
The Journal of infection
| 2022
von
Liu, X.
|
Munro, A.
|
Feng, S.
| +56
CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358
Wird geladen...
5
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ramasamy, M.
|
Minassian, A.
|
Ewer, K.
| +162
ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142
Wird geladen...
6
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST) : a blinded, multicentre, randomised, controlled, phase 2 trial
enthalten in:
Lancet (London, England)
| 2021
von
Munro, A.
|
Janani, L.
|
Cornelius, V.
| +152
ErratumIn: Lancet. 2021 Dec 18;398(10318):2246. - PMID 34922669
Wird geladen...
7
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection : a single-arm substudy of a phase 2/3 clinical trial
enthalten in:
The lancet. HIV
| 2021
von
Frater, J.
|
Ewer, K.
|
Ogbe, A.
| +67
CommentIn: Lancet HIV. 2021 Aug;8(8):e455-e456. - PMID 34153265
Wird geladen...
8
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies
enthalten in:
Cell reports. Medicine
| 2021
von
Willcox, A.
|
Huber, A.
|
Diouf, A.
| +10
Wird geladen...
9
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7) : an exploratory analysis of a randomised controlled trial
enthalten in:
Lancet (London, England)
| 2021
von
Emary, K.
|
Golubchik, T.
|
Aley, P.
| +64
CommentIn: Lancet. 2021 Apr 10;397(10282):1326-1327. - PMID 33798497
Wird geladen...
10
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
enthalten in:
Nature medicine
| 2021
von
Ewer, K.
|
Barrett, J.
|
Belij-Rammerstorfer, S.
| +144
CommentIn: Nat Rev Immunol. 2021 Feb;21(2):70-71. - PMID 33432129
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Clinical Trial, Phase II
Medienart
11
Aufsätze
11
E-Artikel
11
E-Ressourcen
Zeitschriftentitel
4
Lancet (London, England)
3
The Journal of infection
1
Cell reports. Medicine
1
Nature medicine
1
The Lancet. Infectious diseases
1
The lancet. HIV
Alle anzeigen ...
weniger ...
Thema
Clinical Trial, Phase II
11
Journal Article
11
Research Support, Non-U.S. Gov't
9
COVID-19 Vaccines
9
Multicenter Study
9
Randomized Controlled Trial
8
B5S3K2V0G8
8
ChAdOx1 nCoV-19
6
Antibodies, Viral
6
Immunoglobulin G
5
BNT162 Vaccine
4
Antibodies, Neutralizing
3
Clinical Trial, Phase I
3
N38TVC63NU
3
Viral Vaccines
2
COVID-19
2
Clinical Trial, Phase III
2
Immunisation
2
Immunogenicity
2
SARS-CoV-2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
2
2022
6
2021
1
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
11
Englisch
Haven't found what you're looking for?
Wird geladen...